Compositions and methods for the treatment of addiction and other neuropsychiatric disorders

作者: Nicholas E. Goeders

DOI:

关键词: Sympathetic nervous systemPharmacologyActive ingredientAnxiolyticAddictionPrefrontal cortexMedicineDuring menopause

摘要: The present invention is based, in part, on our discovery that certain types of therapeutic agents can be used combination to treat a variety neuropsychiatric and related disorders, including addiction (e.g., substance or an activity) as well alleviate some the symptoms experienced during menopause associated with menstrual cycle. Regardless precise formulation, compositions include at least one active ingredient targets hypothalamo- pituitary-adrenal (HPA) axis prefrontal cortex. Either both these combined agent inhibits activity sympathetic nervous system. Thus, pharmacotherapies also beta-adrenergic receptor otherwise acts anti-hypertensive anxiolytic agent.

参考文章(116)
R. I. Shader, D. J. Greenblatt, A. D. Schatzki, L. G. Miller, S. F. Chesley, J. Deurrutia, Cocaine augments peripheral benzodiazepine binding in humans. The Journal of Clinical Psychiatry. ,vol. 51, pp. 404- 406 ,(1990)
Gregory P. Gasic, Hans C. Breiter, Scott E. Lukas, Igor Elman, Katherine H. Karlsgodt, Acute cortisol administration triggers craving in individuals with cocaine dependence. Psychopharmacology Bulletin. ,vol. 37, pp. 84- 89 ,(2003)
Hélène C, The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anti-cancer Drug Design. ,vol. 6, pp. 569- 584 ,(1991)
Stress Responsive Neurohormones in Depression and Anxiety Pharmacopsychiatry. ,vol. 36, pp. 207- 214 ,(2003) , 10.1055/S-2003-45132
Ketoconazole administration in hypercortisolemic depression. American Journal of Psychiatry. ,vol. 150, pp. 810- 812 ,(1993) , 10.1176/AJP.150.5.810